Amgen is now accepting submissions from promising Massachusetts start-up companies to compete for two highly sought-after Golden Tickets to LabCentral, which will set them up with lab space, amenities, and services at Cambridge’s premier life sciences launchpad as well as access to Amgen’s network of talent and expertise.
All companies with innovative advancements in the cardiovascular and metabolic diseases, oncology, or inflammation therapeutic areas are encouraged to apply, as well as are those focused on making groundbreaking advancements in AI, data science, and manufacturing innovation. Visit the 2020 Amgen-LabCentral Golden Ticket Competition website for full details and to submit your application by October 19, 2020. This is one of the final chances to secure a Golden Ticket to LabCentral in 2020—don’t miss your opportunity!